I am retinal surgeon, stem cell biologist and ocular transplant specialist by trainings, I have over 25-years of international experience in leading and advising some of the most exciting ophthalmic product development from stem cell and gene therapy to drug discovery and delivery across all broad industry ( GSK, Inotek Pharma, Lineage Cells, Astellas Pharma). Recently I pioneered in big data for medicine innovation solving the most difficutl problem that is the 90% drug failure at billion $ cost over a decade of development. From big data I discovered the first curative solution for treating glaucoma blindness with a new approach, this is a breakthrough therapy with anticipated high success. OTI-2024 represents the best in class MMP platform therapy.. Here is our website: http://ophthalmic-innovation.com.